Elicio Therapeutics (ELTX) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $23.00 | Aug 18, 2026 |
| Ladenburg Thalmann | Initiated Coverage | Buy | $12.00 | Jun 18, 2026 |
| Jones Trading | Downgraded | Buy → Hold | — | Jun 16, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $23.00 from $17.00 | Jun 15, 2026 |
| B. Riley Securities | Initiated Coverage | Buy | $27.00 | Jun 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $17.00 | May 28, 2026 |
| Ladenburg Thalmann | Initiated Coverage | Buy | $20.00 | Apr 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $17.00 from $13.00 | Mar 13, 2026 |
| Rodman & Renshaw | Initiated Coverage | Buy | $17.00 | Mar 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $13.00 from $10.00 | Jul 17, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Apr 2, 2025 |
| Jones Trading | Initiated Coverage | Buy | $9.00 | Oct 31, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Aug 23, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Jun 6, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | May 22, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $11.00 | May 1, 2024 |
| Oppenheimer | Maintained | Perform | — | Apr 1, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $10.00 | Jan 17, 2024 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $12.00 | Oct 26, 2023 |
Frequently asked questions
What is the price target for ELTX stock?
The average 12-month analyst price target for Elicio Therapeutics (ELTX) is $20.67, with a high estimate of $27.00 and a low of $12.00, across 3 analysts.
Is ELTX a buy, sell, or hold?
Analysts covering Elicio Therapeutics currently average a Buy rating: 4 buy, 1 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for ELTX?
The average price target of $20.67 implies 652.88% upside from the last price of $2.75.
What is the latest analyst rating on ELTX?
On Aug 18, 2026, HC Wainwright & Co. maintained Elicio Therapeutics at Buy with a price target of $23.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.